ANNALS OF MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2024-04-15 ms4000001908142028 来自浙江省

偏重的研究方向：临床研究
经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2024-03-20 Asmallriver 来自湖南省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：临床研究;感染
经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted

9 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2024-03-24 147398fcm96(暂无昵称) 来自江苏省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：传染病;临床研究
经验分享：SUBMISSION
18 August 2023
Submission Created
18 August 2023
Submission Incomplete
18 August 2023
Manuscript Submitted
18 August 2023
With Journal Administrator
02 January 2024
Submission Returned to Author
03 January 2024
Submission Incomplete
03 January 2024
Manuscript Resubmitted
03 January 2024
With Journal Administrator
PEER REVIEW
08 September 2023
With Editor
07 December 2023
Out for Review
12 December 2023
Decision Pending
14 December 2023
Revision Required
02 January 2024
Revision Incomplete
02 January 2024
Revised Manuscript Submitted
02 January 2024
With Journal Administrator
03 January 2024
With Editor
24 February 2024
Accepted

14 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2024-01-11 123e9c50m50暂无昵称来自上海

2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有

12 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2024-03-24 ms4000001908142028 来自浙江省

偏重的研究方向：临床
经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语

6 0

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2023-01-07 119254319 来自甘肃省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。
10 August 2022
Submission Created
10 August 2022
Submission Incomplete
10 August 2022
Manuscript Submitted
11 August 2022
With Journal Administrator
18 August 2022
Submission Returned to Author
21 August 2022
Submission Incomplete
21 August 2022
Manuscript Resubmitted
21 August 2022
With Journal Administrator
PEER REVIEW
27 September 2022
With Editor
06 November 2022
Out for Review
14 November 2022
Decision Pending
16 November 2022
Revision Required
01 December 2022
Revision Incomplete
01 December 2022
Revised Manuscript Submitted
01 December 2022
With Journal Administrator
11 December 2022
With Editor
03 January 2023
Decision Pending
06 January 2023
Accepted

42 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2023-05-24 shirly008 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：我的过程整体还比较顺利。
03 February 2023
Manuscript Resubmitted
03 February 2023
With Journal Administrator
PEER REVIEW
13 February 2023
With Editor
10 March 2023
Out for Review
12 March 2023
Decision Pending
12 March 2023
Revision Required
25 March 2023
Revision Incomplete
25 March 2023
Revised Manuscript Submitted
25 March 2023
With Journal Administrator
29 March 2023
With Editor
17 May 2023
Decision Pending
17 May 2023
Out for Review
22 May 2023
Accepted

46 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2024-03-06 王哪吒来自山东省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了

16 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2024-03-20 ms3000000233427411 来自福建省

非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2198537, encodeId=28bd219853efc, content=偏重的研究方向：临床研究 经验分享：差不多加上修改一共4个月。接受以后，多久proof？有知道的吗？快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Mon Apr 15 07:03:28 CST 2024, time=2024-04-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194310, encodeId=3eae219431071, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：临床研究;感染 经验分享：慢的很，还好接受了_(:з」∠)_ 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted 01 December 2023 With Editor 25 February 2024 Out for Review 05 March 2024 Decision Pending 05 March 2024 Revision Required 09 March 2024 Revision Incomplete 09 March 2024 Revised Manuscript Submitted 09 March 2024 With Journal Administrator 12 March 2024 With Editor 13 March 2024 Out for Review 15 March 2024 Revision Required 15 March 2024 Revision Incomplete 15 March 2024 Revised Manuscript Submitted 15 March 2024 With Journal Administrator 19 March 2024 With Editor 19 March 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Wed Mar 20 15:31:34 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194988, encodeId=c03b2194988cb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：传染病;临床研究 经验分享：SUBMISSION 18 August 2023 Submission Created 18 August 2023 Submission Incomplete 18 August 2023 Manuscript Submitted 18 August 2023 With Journal Administrator 02 January 2024 Submission Returned to Author 03 January 2024 Submission Incomplete 03 January 2024 Manuscript Resubmitted 03 January 2024 With Journal Administrator PEER REVIEW 08 September 2023 With Editor 07 December 2023 Out for Review 12 December 2023 Decision Pending 14 December 2023 Revision Required 02 January 2024 Revision Incomplete 02 January 2024 Revised Manuscript Submitted 02 January 2024 With Journal Administrator 03 January 2024 With Editor 24 February 2024 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7585200223, createdName=147398fcm96(暂无昵称), createdTime=Sun Mar 24 11:25:37 CST 2024, time=2024-03-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180714, encodeId=23b92180e14f8, content=2023年11月投稿，2周后编辑回复，杂志免费给了文章润色，修改了一下语法。让补充原图及一些声明材料再重新提交。目前提交3周时间了，还在out for review，今天进去发现out for review的时间变更了。搞不清楚是什么问题，前前后后已经快2个月了.....实质进展都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90e22447399, createdName=123e9c50m50暂无昵称, createdTime=Thu Jan 11 09:57:10 CST 2024, time=2024-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2195072, encodeId=004721950e2d8, content=偏重的研究方向：临床 经验分享：不是一般的慢……一审一个来个月，修回两个月没任何动静，催稿问，回复说意见回来了在编辑手里，编辑休假或者不知道干嘛去了，就一直拖着，真的无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4d5408378, createdName=ms4000001908142028, createdTime=Sun Mar 24 17:29:15 CST 2024, time=2024-03-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109312, encodeId=aecf210931201, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：分享一下经验，整个审稿过程偏慢，主要是编辑处理很慢，审稿正常。审稿流程供参考，这是最终的状态，中间很多状态在最终版本中消失了。我的是综述，还算顺利，没有审稿意见，就是让润色一下。 10 August 2022 Submission Created 10 August 2022 Submission Incomplete 10 August 2022 Manuscript Submitted 11 August 2022 With Journal Administrator 18 August 2022 Submission Returned to Author 21 August 2022 Submission Incomplete 21 August 2022 Manuscript Resubmitted 21 August 2022 With Journal Administrator PEER REVIEW 27 September 2022 With Editor 06 November 2022 Out for Review 14 November 2022 Decision Pending 16 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 11 December 2022 With Editor 03 January 2023 Decision Pending 06 January 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Sat Jan 07 21:23:01 CST 2023, time=2023-01-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2138890, encodeId=ac822138890ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：我的过程整体还比较顺利。 03 February 2023 Manuscript Resubmitted 03 February 2023 With Journal Administrator PEER REVIEW 13 February 2023 With Editor 10 March 2023 Out for Review 12 March 2023 Decision Pending 12 March 2023 Revision Required 25 March 2023 Revision Incomplete 25 March 2023 Revised Manuscript Submitted 25 March 2023 With Journal Administrator 29 March 2023 With Editor 17 May 2023 Decision Pending 17 May 2023 Out for Review 22 May 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a051634531, createdName=shirly008, createdTime=Wed May 24 22:03:17 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191393, encodeId=b5302191393de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：垃圾杂志，23年9月开始投 1月份发来返修，返修提交后等待一个月后被录用，7天后又被执行编辑拒绝，真恶心，白浪费半年那么久。写的纯生信，也给审稿人解释为什么没做实验验证，审稿人那边接受了，结果又被杂志社以没有实验验证为由拒绝发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aa18639981, createdName=王哪吒, createdTime=Wed Mar 06 11:50:22 CST 2024, time=2024-03-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194309, encodeId=e9b42194309cb, content=非常恶心的期刊，外审后说小修，修回后，第二天直接拒。整个人都傻了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b18550137, createdName=ms3000000233427411, createdTime=Wed Mar 20 15:30:40 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2184234, encodeId=a55021842346e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：药学 经验分享：在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62d46153287, createdName=ms2000001469312267, createdTime=Sat Jan 27 02:26:43 CST 2024, time=2024-01-27, status=1, ipAttribution=)]

2024-01-27 ms2000001469312267

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：药学
经验分享：在外审

26 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务